Sodium iodide Completed Phase 1 Trials for Invasive Breast Carcinoma / Progesterone Receptor Positive / Estrogen Receptor Negative / Triple Negative Breast Carcinoma / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Recurrent Head and Neck Carcinoma / Progesterone Receptor Negative / Carcinoma Breast Stage IV / Estrogen Receptor Positive / HER2-positive / HER2 negative Treatment

Indications	Status	Purpose	Phase
DBCOND0031787 (Invasive Breast Carcinoma) DBCOND0031390 (Progesterone Receptor Positive) DBCOND0036417 (Estrogen Receptor Negative) DBCOND0129280 (Triple Negative Breast Carcinoma) DBCOND0035874 (Squamous Cell Carcinoma of the Head and Neck (SCCHN)) DBCOND0058166 (Recurrent Head and Neck Carcinoma) DBCOND0038639 (Progesterone Receptor Negative) DBCOND0032879 (Carcinoma Breast Stage IV) DBCOND0031389 (Estrogen Receptor Positive) DBCOND0135420 (HER2-positive) DBCOND0024919 (HER2 negative)	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01846091	Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer	Measles virus vaccine live attenuated (DB10315) Sodium iodide (DB11119)